Formosa Laboratories
Formosa Laboratories, also known as Formosa, is a leading player in the pharmaceutical and biotechnology industry, headquartered in Taiwan (TW). Founded in 1996, the company has established a strong presence in key operational regions, including North America and Europe, focusing on the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and intermediates. With a commitment to innovation, Formosa Laboratories offers a diverse range of products and services, including custom synthesis and contract manufacturing. Their unique approach combines advanced technology with stringent quality control, ensuring compliance with global regulatory standards. Recognised for its expertise, Formosa has achieved significant milestones, positioning itself as a trusted partner in the pharmaceutical supply chain.
DitchCarbon Score
How does Formosa Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Formosa Laboratories's score of 40 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Formosa Laboratories's reported carbon emissions
In 2023, Formosa Laboratories reported total carbon emissions of approximately 56,549,310.2 kg CO2e. This figure includes about 27,042,350.4 kg CO2e from Scope 2 emissions, primarily from purchased electricity, and approximately 11,757,256.9 kg CO2e from Scope 3 emissions, which encompass business travel and purchased goods and services. The combined Scope 1 and 2 emissions totalled around 35,463,870.6 kg CO2e. Comparatively, in 2022, the company’s total emissions were about 44,783,921.3 kg CO2e, with Scope 2 emissions at approximately 25,787,124.0 kg CO2e and Scope 3 emissions at around 3,039,376.4 kg CO2e. This indicates a significant increase in emissions from 2022 to 2023. Formosa Laboratories has been actively conducting greenhouse gas inventories since 2021, aligning with the government’s 2050 net-zero transition policy. The company has set long-term climate commitments to achieve net-zero emissions across all scopes by 2050, reflecting its dedication to global carbon reduction trends. However, specific reduction targets or achievements have not been disclosed. The emissions data is not cascaded from any parent organization, and all figures are reported directly from Formosa Laboratories, Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 633,680 | - | - |
| Scope 2 | 31,949,430 | 00,000,000 | 00,000,000.0 |
| Scope 3 | - | 0,000,000.0 | 00,000,000.0 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Formosa Laboratories is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
